New findings about the development of diabetic retinopathy represents a shift in the long-term understanding of these diabetes complications.
After examining more than 25,000 patients, researchers found that by using a new scanning technology, diabetic retinopathy can be identified from a remote location by experts who can then recommend a course of action.
A large new study, published in the journal Ophthalmology, reveals previously unknown risk factors associated with keratoconus, an eye condition that causes serious progressive nearsightedness at a relatively young age.
Results of a recent study show that Lucentis is highly effective at treating proliferative diabetic retinopathy and may be an alternative to laser therapy. This is the first major advance in eyesight-preserving therapy in decades and big news considering the many millions of people who have diabetic retinopathy.
Researchers from University of Nottingham have developed software that helps predict the risk of blindness and amputation in people living with type 1 or type 2 diabetes. A free online tool is available and it takes less than a minute to get results.
Researchers have succeeded in producing photoreceptors from human embryonic stem cells, which can help restore vision in people suffering from macular degeneration.
Damage in retinal periphery closely matches loss of blood flow in people with diabetes and a different imaging test may aid in earlier detection and treatment.
A new study finds that taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes.
Several recently developed drugs slow progression to proliferative diabetic retinopathy, but do not reliably prevent it. New research points to a new treatment that can be combined with current drugs to prevent many cases of proliferative diabetic retinopathy.
Personalized education and risk assessment for people with diabetes visiting the ophthalmologist did not improve hemoglobin A1c levels or glycemic control.